The AG1 Experience: Omega3

2 MIN READ — 12/27/2024

Foundational Nutrition in a single, comprehensive daily health drink is what AG1 is known for, and a scoop of our powder offers a multivitamin, a multimineral, prebiotics, probiotics, superfoods and adaptogens. But there are a few vital nutrients that are best delivered in a separate form. So in addition to our AG1 powder, we make AG Omega3 softgels and concentrated AG Vitamin D3+K2 drops.

Omega-3s are polyunsaturated fatty acids. EPA and DHA, found in fish oil, are the two types of omega-3s considered most beneficial to whole-body health. ALA is an omega-3 found in plants. Our bodies can convert some ALA into EPA and DHA, but not in sufficient amounts. We formulate our AG Omega3 fish-oil softgels as a separate product from AG1 to ensure we’re offering the highest-quality and most highly absorbable forms of EPA and DHA, while keeping AG1 simple to use, water soluble and vegan.

It’s vital to get EPA and DHA from food or supplement sources. U.S. Dietary Guidelines for Americans recommends 450 to 500 mg of EPA and DHA per day, but the typical American diet contains fewer than 100 mg. Taking supplemental omega-3s in the form of EPA and DHA is important in closing the nutritional gap.

EPA and DHA support both heart and brain health. They aid in metabolic function, encourage normal arterial function and help maintain the structure and function of the brain. (As the majority of the brain is made up of fat, fatty acids are essential for cognitive health.) They also support cognitive performance. Because these systems are so vital to whole-body health, AG Omega3 delivers 2,000 mg of EPA and DHA in the most bioavailable form.

We sustainably source our fish oil from wild-caught, small fish, and it’s then molecularly distilled for purity and quality. A hit of lemon in the formulation for taste makes it easy to incorporate daily as part of your AG1 Foundational Nutrition plan. After all, one-and-done has an undeniable appeal, but good things come in threes.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Information on the AG1 site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular health care provider.

** Offer valid for first time subscribers only.

Actual Packaging May Vary

  1. In a triple-blind, randomized, placebo-controlled parallel-designed clinical trial evaluating nutrient biomarkers and microbiome shifts in 105 healthy adults ages 20-59 over the course of 12 weeks.
  2. In a double-blind, randomized, placebo-controlled 2-week crossover clinical trial assessing nutrient gaps and microbiome shifts in 20 active adults ages 19-37.
  3. In a double-blind, randomized, placebo-controlled 2-week crossover clinical trial assessing nutrient gaps and microbiome assessments of 40 healthy adults with occasional GI distress ages 26-59 over the course of 4 weeks.
  4. In a double-blind, randomized, placebo-controlled crossover clinical trial assessing nutrient gaps and bioavailability in 16 healthy adults ages 18-42 over the course of 8 hours.
  5. In a third-party, single-arm, closed label interventional study of 104 healthy adults ages 25-9 assessing self-perceived efficacy of AG1 Next Gen over 3 months.